Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Moderna a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary ...
read more
Pfizer announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the coadministration of the company’s 20-valent ...
read more
AstraZeneca’s COVID-19 vaccine, Vaxzevria, has been granted special approval for emergency use in Japan for active immunization of individuals aged 18 years and older, to prevent COVID-19 caused by ...
read more
Pfizer Inc. and BioNTech announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the European Union (EU), with an ...
read more
FDA’s Clinical Methodologies Group (ClinMeth) received a $9.2 million grant through the HHS Office of the Assistant Secretary for Planning and Evaluation’s (ASPE) Patient-Centered Outcomes Research ...
read more
Pfizer Inc. and BioNTech announced that BioNTech Europe has entered an agreement with Turkey’s Ministry of Health to supply 60 million additional doses of the companies’ COVID-19 vaccine, with an ...
read more
Maxwell Biosciences, a biotechnology company, announced patented biostable peptide analogs that function as mimics of the cathelicidin peptide - the human body’s primary virus immunity molecule.
read more
APEIRON Biologics, a private European biotech company, announced next steps for APN01 (alunacedase alfa) for COVID-19 treatment.
Based on the results from APEIRON’s Phase 2 trial with COVID-19, APN01...
read more
The emergence of more infectious variants of the COVID-19 virus is threatening to slow the global recovery and potentially thwart current vaccine immunity.
read more
Labcorp has announced that the FDA has granted Emergency Use Authorization for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17.
read more
Pfizer Inc. and BioNTech SE announced that the FDA has expanded the Emergency Use Authorization for their COVID-19 vaccine to include individuals 12 to 15 years of age.
read more
Pfizer Inc. and BioNTech SE have announced the initiation of a Biologics License Application with the FDA for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and ...
read more
Pfizer and BioNTech to donate the companies’ COVID-19 vaccine to help vaccinate athletes, and their delegations, participating in the Olympic and Paralympic Games Tokyo 2020.
read more
Lonza has announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-...
read more
Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine.
read more